Top Markets
Coin of the day
Tetra Bio-Pharma Inc. Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Inc.

TBP
Rang in aandelen #35576
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
Aandeelprijs
$0.01851783
Laatst gesynchroniseerd: 2023-05-23
Marktkapitalisatie
$3.71M
Verandering (1 dag)
-0.04%
Verandering (1 jaar)
0.00%
Land
CA
Handel Tetra Bio-Pharma Inc. (TBP)

Categorie

Koersgeschiedenis voor Tetra Bio-Pharma Inc. (TBP)
Hoogste slotkoers: $0.02 op 2023-05-01

Laagste slotkoers: $0.47 op 2018-07-01
Koersgeschiedenis van Tetra Bio-Pharma Inc. van 2018 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2023 3.94%
2022 -84.88%
2021 -20.47%
2020 -60.18%
2019 -40.49%
2018 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE